FY25 Docker Enterprise Edition Licenses
ID: FDA-75F40125Q00007Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFFOOD AND DRUG ADMINISTRATIONFDA Office of Acquisitions and Grants ServicesRockville, MD, 20857, USA

NAICS

Other Computer Related Services (541519)

PSC

IT AND TELECOM - BUSINESS APPLICATION SOFTWARE (PERPETUAL LICENSE SOFTWARE) (7A21)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/221798ecc67d45f4bd68df4a678569ee/view
Timeline
    Description

    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking proposals for the procurement of Docker Enterprise Edition licenses to support the development of its Containers as a Service (CaaS) platform. The objective of this contract is to enhance the FDA's IT infrastructure by utilizing Docker EE’s container technology, which is essential for improving operational efficiency and reducing costs compared to traditional virtual machines. This procurement is significant as it enables the FDA to deploy applications in various environments while ensuring compliance with federal security mandates. Interested small businesses must submit their quotes by January 2, 2025, and can direct inquiries to Terina Hicks at terina.hicks@fda.hhs.gov or Roosevelt Walker at roosevelt.walker@fda.hhs.gov.

    Point(s) of Contact
    Terina Hicks
    terina.hicks@fda.hhs.gov
    Roosevelt Walker
    roosevelt.walker@fda.hhs.gov
    Files
    Title
    Posted
    RFQ FDA-75F40125Q00007_Revised.pdf
    The FDA's Request for Quote (RFQ) FDA-75F40125Q00007 seeks proposals for renewing Docker Enterprise Edition software licenses, essential for developing the FDA's Containers as a Service (CaaS) platform. The RFQ is structured under FAR Part 12 and aims for a fixed-price contract lasting one year, set aside for small businesses under NAICS code 541519. The purpose of this procurement is to leverage Docker EE’s container technology, enhancing FDA’s infrastructure by increasing operational efficacy and reducing costs compared to traditional virtual machines. Essential requirements include deployment capabilities in diverse environments (air-gapped and internet-connected), high availability modes, independent upgradability, and robust security measures adhering to government compliance mandates (NIST, FISMA, FIPS). Deliverables include kick-off meetings, delivery schedules, and progress reports. Quotes are due by January 2, 2025. This acquisition highlights the FDA's commitment to modernizing its IT infrastructure, ensuring agile application deployment, and complying with federal procurement standards. The document outlines details on delivery, contract management, and invoicing, emphasizing transparency and rigorous compliance for all parties involved.
    RFQ FDA-75F40125Q00007.pdf
    The document outlines the Request for Quote (RFQ) FDA-75F40125Q00007 for Docker Enterprise Edition licenses aimed at the renewal of Containers as a Service (CaaS) solutions for the FDA. This initiative falls under federal acquisition procedures and involves a one-year contract, designated as a Total Small Business set-aside. The FDA seeks to modernize its IT infrastructure by leveraging Docker's technology to improve application deployment, enhance efficiency, and reduce operational costs. Key requirements include support for both air-gapped and online environments, high availability, multi-tenant capability, and robust networking and security features compliant with government standards. The contract stipulates necessary functionalities for application development, monitoring, and data storage, emphasizing self-healing capabilities and detailed resource management. Deliverables consist of a series of reports and schedules throughout the contract period from February 18, 2025, to February 17, 2026. The document also specifies bidding requirements, payment terms, and contract management details. Overall, this RFQ reflects the FDA's commitment to advancing its IT capabilities using leading-edge technology while adhering to federal procurement policies.
    Lifecycle
    Title
    Type
    FY25 Docker Enterprise Edition Licenses
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    PRIMO Software Licensing
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified small businesses to provide PRIMO Software Licensing and Maintenance Support Services. The procurement involves supplying 21 PRIMO software licenses for a base year, with two additional option years, to ensure the continuous operation of the FDA's CFSAN CAEMS system. This software is crucial for pharmacovigilance and regulatory compliance, enhancing the FDA's capabilities in monitoring food safety. Interested parties must submit their quotes by August 26, 2024, and are encouraged to contact Roosevelt Walker at roosevelt.walker@fda.hhs.gov for further details. The contract will be awarded as a firm-fixed-price purchase order, emphasizing compliance with federal acquisition regulations and accessibility standards.
    FDA Regulated Products Sampling Services
    Active
    Health And Human Services, Department Of
    The U.S. Food and Drug Administration (FDA) is seeking qualified vendors to provide Sampling Services for FDA-regulated products through a Sources Sought Notice (Ref No. 75F40125R00032). The primary objective of this procurement is to identify capable businesses that can collect physical samples of food, drugs, medical devices, and other products for laboratory analysis, ensuring safety and verifying labeling accuracy. This initiative is crucial for the FDA's regulatory oversight, as it supports the monitoring of product safety and quality, which may include both domestic and imported goods. Interested parties must submit their responses by January 9, 2025, and can contact Amanda Lusk at Amanda.Lusk@fda.hhs.gov or Nicholas Bisher at Nicholas.Bisher@fda.hhs.gov for further information.
    MRC Biosafety Cabinet Evaluation
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), is seeking qualified small businesses to provide engineering evaluation services for biological safety cabinets (BSCs) at its Center for Veterinary Medicine. The primary objective of this procurement is to assess existing BSCs that are failing to meet certification standards, particularly focusing on their associated HVAC and control systems, and to provide recommendations for replacements. This evaluation is crucial for maintaining laboratory safety and operational efficiency, ensuring compliance with federal safety standards. Interested parties must attend a mandatory site visit on December 17, 2024, and submit their quotations by January 8, 2025, to the contracting officer, Sheneil Green, at Sheneil.Green@fda.hhs.gov.
    Bruker Maldi TOF Maintenance
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), is seeking proposals for a full-service maintenance agreement for its Bruker MALDI TOF system, with a contract start date of January 16, 2025, and four optional one-year extensions. The contractor will be responsible for comprehensive maintenance services, including all repairs, annual preventative maintenance, and ensuring compliance with regulatory standards, with a focus on supporting the FDA's mission to monitor antimicrobial resistance in foodborne and zoonotic pathogens. Interested small businesses must submit their quotes by 11:59 PM EST on January 3, 2025, and can direct inquiries to James O’Keefe at 301-796-7371 or via email at James.OKeefeIII@fda.hhs.gov.
    QIACube Maintenance Agreement
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking proposals for a maintenance agreement for its QIACube system, essential for the Atlanta Human and Animal Food Laboratory's molecular biology operations. The procurement requires a comprehensive service agreement that includes repair, labor, travel, and a loaner instrument, ensuring compliance with ISO accreditation standards and continuity in critical DNA and RNA extraction processes. The contract will commence on February 1, 2025, and run for one year, with options for four additional years, and proposals are due by 11:59 PM EST on January 3, 2025. Interested vendors can contact James O’Keefe at 301-796-7371 or via email at James.OKeefeIII@fda.hhs.gov for further information.
    FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is soliciting proposals through the FY25 Broad Agency Announcement (BAA) aimed at advancing regulatory science and innovation. This opportunity invites organizations, particularly small businesses, to submit research and development proposals that address critical areas such as alternative drug development methods, advanced manufacturing technologies, and predictive toxicology, with a strong emphasis on including diverse populations in research. Proposals must be submitted by February 24, 2025, and will undergo a two-tier evaluation process, with the potential for multiple contracts awarded based on proposal quality and funding availability. Interested parties can contact Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.
    Safe Medication Use
    Active
    Health And Human Services, Department Of
    The U.S. Food and Drug Administration (FDA) is conducting a Request for Information (RFI) to identify potential sources capable of providing medication error reports, an analytics platform, and related services aimed at preventing and analyzing medication errors. This initiative, led by the FDA's Center for Drug Evaluation and Research, seeks organizations that can supply nationwide data from healthcare providers, consumers, and patient safety organizations, emphasizing the importance of robust reporting, data analysis, and training in enhancing medication safety protocols. Interested parties, particularly small businesses, are encouraged to submit their capability statements by January 6th, 2025, and should note that responses are voluntary and do not imply a commitment for a contract. For further inquiries, contact Brian Wodzisz at Brian.Wodzisz@fda.hhs.gov or call 301-796-7376.
    Access to the Florence electronic Trial Master File (eTMF) Platform- 12 Months Annual Subscription
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to procure a 12-month annual subscription to the Florence electronic Trial Master File (eTMF) platform. This non-competitive solicitation aims to secure a commercial item necessary for secure data storage and management for the Rare Disease Clinical Research Network (RDCRN) program, ensuring continuity and compliance with existing systems currently in use. Interested vendors must submit their quotations by 1:00 p.m. Eastern Time on December 24, 2024, referencing Solicitation Number 75N95025Q00050, and can direct inquiries to Samson Shifaraw at samson.shifaraw@nih.gov or by phone at 301-480-7153.
    FY24 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Award Notice
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), has announced the FY24 Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science. This opportunity aims to support innovative research projects that enhance regulatory science, with a focus on health, medical, and biotechnology advancements. The awarded contracts, totaling over $24 million, cover a range of critical topics including drug safety, gene therapy, and methodologies for assessing pediatric opioid exposure, reflecting the federal government's commitment to fostering research initiatives that improve healthcare delivery and regulatory processes. Interested parties can contact Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.
    Solicitation: Tobacco Retailer Inspections - 75F40125R00018
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), is soliciting proposals for an Indefinite Delivery/Indefinite Quantity (IDIQ) contract to conduct tobacco retailer inspections under solicitation number 75F40125R00018. The primary objective of this procurement is to ensure compliance with federal laws regarding the sale and advertising of tobacco products, particularly focusing on preventing youth access to these products across multiple regions in the United States. This initiative is crucial for enhancing the FDA's enforcement capabilities and protecting public health by reducing tobacco use among youth. Interested contractors should contact Janice Heard at janice.heard@fda.hhs.gov or Brandon Rafus at brandon.rafus@fda.hhs.gov for further details, with the contract period spanning five years and funding amounts varying by region.